Stockreport

Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program

Cumberland Pharmaceuticals Inc.  (CPIX) 
Last cumberland pharmaceuticals inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.shareholder.com/cpix/index.cfm
PDF NASHVILLE, Tenn., Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for [Read more]